Search

Pietro Morlacchi

from Concord, MA
Age ~52
Get Report
Also known as:
Morlacchi Pietro
Connected to:
Jay M Morlachetta, 46Beth R Morlan, 30Dan W Morlan, 83Janet Morlan, 60Jared Morlan, 38Jason R Morlan, 40Joelle M Morlan, 46Jon A Morlan, 61Kendall J Morlan, 63Lucy A Morlan, 44

Pietro Morlacchi Phones & Addresses

  • Concord, MA
  • Bedford, MA
  • Houston, TX

Work

Company: Md anderson cancer center Oct 2011 Position: Postdoctoral fellow, experimental therapeutics

Education

Degree: PhD School / High School: Rice University 2005 to 2009 Specialities: Chemistry

Skills

Molecular Biology • Protein Chemistry • Cell Culture • Western Blotting • Chemistry • Biochemistry • Mass Spectrometry • Pcr • Nmr • Cancer • Microbiology • Chromatography • Gel Electrophoresis • Gc Ms • Molecular Cloning • Metabolomics

Languages

English • Italian

Industries

Research

Resumes

Resumes

Pietro Morlacchi Photo 1

Application Scientist - Metabolomics

View page
Location:
1306 Taylor Pond Ln, Bedford, MA 01730
Industry:
Research
Work:
MD Anderson Cancer Center since Oct 2011
Postdoctoral Fellow, Experimental Therapeutics
Rice University Aug 2005 - Jul 2009
PhD in Chemistry
Consiglio Nazionale delle Ricerche Feb 2005 - May 2005
Research assistant
Consiglio Nazionale delle Ricerche Nov 2003 - Feb 2005
Research assistant
Consiglio Nazionale delle Ricerche Nov 2002 - Sep 2003
Undergraduate research assistant
Education:
Rice University 2005 - 2009
PhD, Chemistry Rice University 2005 - 2007
MA, Chemistry Università degli Studi di Roma 'La Sapienza' 2005
Laurea (MS/BS), Chemistry
Skills:
Molecular Biology
Protein Chemistry
Cell Culture
Western Blotting
Chemistry
Biochemistry
Mass Spectrometry
Pcr
Nmr
Cancer
Microbiology
Chromatography
Gel Electrophoresis
Gc Ms
Molecular Cloning
Metabolomics
Languages:
English
Italian

Publications

Wikipedia

Francesco Morlacchi

View page

Francesco Morlacchi (14 June 1784 - 28 October 1841) was an Italian composer of ... "The Swiss Shepherd" was instead written by Italian flutist Pietro Morlacchi ...

Us Patents

Nerolidol, Terpene, And Terpene Deriviative Synthesis

View page
US Patent:
20100062504, Mar 11, 2010
Filed:
Dec 12, 2007
Appl. No.:
12/516164
Inventors:
Caroline Virginia McNeil - Houston TX, US
Pietro Morlacchi - Houston TX, US
Alyssa Baevich - Richmond TX, US
Seiichi Paul Tillich Matsuda - Houston TX, US
International Classification:
C12P 7/04
US Classification:
435157
Abstract:
According to one embodiment, the description relates to a method of nerolidol production. The method includes culturing a yeast strain lacking functional squalene synthase and overproducing HMG CoA reductase in synthetic medium lacking uracil and producing nerolidol. The pH of the medium may be adjusted to an acidic level to further increase nerolidol production. Other chemicals may also be produced by this method. The nerolidol or other chemicals may be removed from the yeast or medium or both. The medium may additionally contain a polyaromatic resin, which may adsorb nerolidol or other chemicals.

Stat6 Inhibitors

View page
US Patent:
20180222931, Aug 9, 2018
Filed:
Aug 16, 2017
Appl. No.:
15/678127
Inventors:
- Austin TX, US
- Houston TX, US
Pietro MORLACCHI - Houston TX, US
Morgan KNIGHT - Houston TX, US
David B. CORRY - Houston TX, US
Assignee:
Board of Regents, The University of Texas System - Austin TX
Baylor College of Medicine - Houston TX
International Classification:
C07F 9/6561
C07K 5/062
C07F 9/6533
C07F 9/12
C07F 9/572
C07F 9/6558
C07F 9/553
A61K 9/00
A61K 45/06
C07F 9/62
C07F 9/60
C07F 9/6509
C07K 5/078
Abstract:
The present disclosure provides compounds that are useful for inhibiting the STAT6 pathway. Also provided are related pharmaceutical compositions and methods of using the compounds. In some embodiments, the compounds may be used to treat a disease such as, e.g., an allergic lung disease, allergic rhinitis, chronic pulmonary obstructive disease, or a cancer.

Stat6 Inhibitors

View page
US Patent:
20160145279, May 26, 2016
Filed:
May 8, 2014
Appl. No.:
14/889802
Inventors:
- Austin TX, US
- Houston TX, US
Pietro MORLACCHI - Houston TX, US
Morgan KNIGHT - Houston TX, US
David B. CORRY - Houston TX, US
Assignee:
Baylor College of Medicine - Houston TX
Board of Regents, The University of Texas System - Austin TX
International Classification:
C07F 9/6561
C07F 9/553
C07F 9/62
C07F 9/6533
C07F 9/6509
C07F 9/60
C07F 9/572
C07F 9/6558
Abstract:
The present disclosure provides compounds that are useful for inhibiting the STAT6 pathway. Also provided are related pharmaceutical compositions and methods of using the compounds. In some embodiments, the compounds may be used to treat a disease such as, e.g., an allergic lung disease, allergic rhinitis, chronic pulmonary obstructive disease, or a cancer.
Control profile
Pietro Morlacchi from Concord, MA, age ~52 Get Report